206 related articles for article (PubMed ID: 31477006)
1. Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma.
Lei H; Liu W; Si J; Wang J; Zhang T
BMC Bioinformatics; 2019 Sep; 20(1):449. PubMed ID: 31477006
[TBL] [Abstract][Full Text] [Related]
2. Analysis of NFKB2‑mediated regulation of mechanisms underlying the development of Hodgkin's lymphoma.
Zhang Y; Tong L; Chen S; Wu W; Wang L
Mol Med Rep; 2018 Jun; 17(6):8129-8136. PubMed ID: 29693141
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA and gene networks in human Hodgkin's lymphoma.
Zhu M; Xu Z; Wang K; Wang N; Zhu M; Wang S
Mol Med Rep; 2013 Dec; 8(6):1747-54. PubMed ID: 24145479
[TBL] [Abstract][Full Text] [Related]
4. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
5. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
7. Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs.
Zafari S; Backes C; Leidinger P; Meese E; Keller A
Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):159-68. PubMed ID: 26169798
[TBL] [Abstract][Full Text] [Related]
8. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2009 Feb; 11(2):167-76. PubMed ID: 19177201
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
[TBL] [Abstract][Full Text] [Related]
12. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
13. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
14. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
16. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
17. Network analysis of microRNAs, genes and their regulation in mantle cell lymphoma.
Deng SY; Guo XX; Wang N; Wang KH; Wang S
Asian Pac J Cancer Prev; 2015; 16(2):457-63. PubMed ID: 25684471
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
19. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P
Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047
[TBL] [Abstract][Full Text] [Related]
20. Screening candidate microRNA-mRNA regulatory pairs for predicting the response to chemoradiotherapy in rectal cancer by a bioinformatics approach.
Peng Q; Zhu J; Shen P; Yao W; Lei Y; Zou L; Xu Y; Shen Y; Zhu Y
Sci Rep; 2017 Sep; 7(1):11312. PubMed ID: 28900297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]